Security Snapshot

MESA LABORATORIES INC /CO/ - Common Stock, no par value (MLAB) Institutional Ownership

CUSIP: 59064R109

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

159

Shares (Excl. Options)

4,824,431

Price

$88.42

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+88,010
Value change
+$11,851,440
Number of holders
159
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
5,555,932
SEC-reported price per share
$90.80
Insider filing price
$90.80
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • MLAB - MESA LABORATORIES INC /CO/ - Common Stock, no par value is tracked under CUSIP 59064R109.
  • 159 institutions reported positions in Q1 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 158 to 159 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $372,211,358 to $426,315,836.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 159 institutions filings for Q1 2026.

Open SEC evidence

Security key

59064R109

Latest holder period

Q1 2026

13F holders

159

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
MLAB
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Conestoga Capital Advisors, LLC 11% $71,997,569 618,111 Conestoga Capital Advisors 31 Dec 2024
Long Path Smaller Companies Fund, LP 7.3% +28% $35,870,044 +$8,302,813 405,583 +30% Long Path Smaller Companies Fund, LP 31 Mar 2026
BlackRock, Inc. 6.9% -54% $24,158,473 -$25,762,419 378,897 -52% BlackRock, Inc. 30 Sep 2025
ROYCE & ASSOCIATES LP 5% -6% $31,579,825 -$1,874,047 271,118 -5.6% ROYCE & ASSOCIATES LP 31 Mar 2025

As of 31 Mar 2026, 159 institutional investors reported holding 4,824,431 shares of MESA LABORATORIES INC /CO/ - Common Stock, no par value (MLAB). This represents 87% of the company’s total 5,555,932 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
69%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Long Path Partners LP 7.3% 405,583 +78% 16% $35,861,649
BlackRock, Inc. 7.1% 393,851 -1.2% 0% $34,824,305
Boston Partners 4.8% 268,711 +26% 0.03% $23,762,126
Select Equity Group, L.P. 4.2% 235,885 +14% 0.11% $20,856,952
VANGUARD CAPITAL MANAGEMENT LLC 4.2% 232,643 0% 0% $20,570,294
Ranger Investment Management, L.P. 3.7% 202,903 -1.1% 1.3% $17,940,683
AQR CAPITAL MANAGEMENT LLC 3.1% 170,562 +143% 0.01% $15,081,098
MORGAN STANLEY 2.9% 162,116 -7.7% 0% $14,334,351
ROYCE & ASSOCIATES LP 2.9% 161,229 +5.1% 0.14% $14,255,868
DIAMOND HILL CAPITAL MANAGEMENT INC 2.8% 155,302 +9.4% 0.09% $13,731,803
KENNEDY CAPITAL MANAGEMENT LLC 2.6% 142,343 -1.6% 0.27% $12,585,968
Russell Investments Group, Ltd. 2.4% 135,069 +16% 0.01% $11,942,874
GEODE CAPITAL MANAGEMENT, LLC 2.3% 128,002 +0.04% 0% $11,321,083
DIMENSIONAL FUND ADVISORS LP 2.2% 124,630 +7.1% 0% $11,017,953
RAYMOND JAMES FINANCIAL INC 2.2% 122,911 +22% 0% $10,691,384
STATE STREET CORP 2.2% 122,068 +1.2% 0% $10,793,253
MONIMUS CAPITAL MANAGEMENT, LP 1.8% 101,292 +148% 2.5% $8,956,239
CRAWFORD INVESTMENT COUNSEL INC 1.7% 95,535 +18% 0.14% $8,447,205
Roubaix Capital, LLC 1.3% 72,115 +31% 3% $6,376,408
GOLDMAN SACHS GROUP INC 1.3% 70,617 +28% 0% $6,243,956
JANUS HENDERSON GROUP PLC 1.2% 69,401 -41% 0% $6,136,436
NORTHERN TRUST CORP 1.2% 69,264 +5.5% 0% $6,124,324
Meros Investment Management, LP 1.2% 68,032 -20% 2.6% $6,015,389
GABELLI FUNDS LLC 1.1% 62,499 +2.9% 0.04% $5,526,162
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 62,424 +0.83% 0% $5,519,530

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 4,824,431 $426,315,836 +$11,851,440 $88.42 159
2025 Q4 4,741,474 $372,211,358 +$2,391,653 $78.50 158
2025 Q3 4,981,288 $333,781,447 -$17,563,084 $67.01 139
2025 Q2 5,194,339 $489,420,814 +$3,151,880 $94.22 154
2025 Q1 5,170,743 $613,627,994 +$6,492,344 $118.66 151
2024 Q4 5,103,701 $673,040,010 +$27,103,138 $131.87 156
2024 Q3 4,893,266 $633,592,675 -$1,799,578 $129.86 165
2024 Q2 4,891,845 $424,757,234 -$2,285,633 $86.77 150
2024 Q1 4,866,455 $534,319,569 +$2,912,009 $109.73 154
2023 Q4 4,844,406 $507,454,547 -$6,592,200 $104.77 158
2023 Q3 4,901,538 $515,000,677 +$6,025,097 $105.07 152
2023 Q2 4,832,223 $620,943,111 -$24,453,662 $128.50 157
2023 Q1 5,023,401 $877,732,676 -$2,517,173 $174.73 157
2022 Q4 5,085,374 $846,760,262 +$70,304,664 $166.21 155
2022 Q3 4,842,604 $681,105,708 -$11,702,600 $140.83 159
2022 Q2 4,908,949 $1,000,923,113 +$11,794,155 $203.94 168
2022 Q1 4,859,392 $1,238,083,828 +$14,735,450 $254.88 168
2021 Q4 4,791,533 $1,570,225,457 +$6,590,466 $328.09 173
2021 Q3 4,766,186 $1,441,093,898 +$17,124,814 $302.36 171
2021 Q2 4,707,819 $1,276,759,656 +$27,150,060 $271.17 157
2021 Q1 4,611,973 $1,124,183,042 -$29,099,250 $243.50 171
2020 Q4 4,708,471 $1,349,635,260 -$19,634,872 $286.64 174
2020 Q3 4,781,094 $1,219,323,749 +$30,338,136 $254.76 152
2020 Q2 4,672,474 $1,012,950,025 +$111,113,576 $216.80 165
2020 Q1 4,158,000 $940,428,089 +$24,185,487 $226.09 143
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .